Webinar

Going omnichannel? Don’t forget your modular content toolkit: the 5 reasons why

Viseven at next normal 2022

Pharmaceutical companies are developing ways to adopt omnichannel communication practices – and there are some industry-specific caveats. Planning and executing a proper campaign in life sciences means you have to transplant the vast knowledge from other industries (like customer journey building) into a new context while also dealing with content.

How to gain this knowledge?

On April 28 at 4:00 PM CET, industry experts got together at Next Normal to discuss the interconnection between omnichannel campaigning in pharma and the innovative modular content approach: splitting content into flexible reusable blocks that are MLR-preapproved and channel-agnostic.

Agenda:

  • Building an omnichannel campaign in practice: prerequisites, insights, goals
  • Findings from actual projects, and the role of personalized content
  • Why content personalization involves standardization “backstage”
  • How modular approach can be used as a key to unlock omnichannel for the industry

Speakers:

1. Nataliya Andreychuk – Chief Executive Officer at Viseven
2. Pavel Klymenko – Head of Omnichannel / Multichannel Excellence at Viseven
3. José Ma. Guido Avila – Customer Engagement Transformation Lead at Sanofi
4. Romika Bhowmick – Associate Director Commercial Platforms Strategy at Teva

Please fill out the form below if you would like to watch the Next Normal webinar recording.

Request recording:

Latest News

May 16, 2022

Viseven and Next Pharma Partnership Announcement

Viseven is happy to share its latest business venture – a partnership with NEXT. The two companies join forces to positively impact the future of the
May 11, 2022

24/7 Content Factory: Center of Excellence in India  

We are proud to announce the development of our latest business venture – a brand new Center of Excellence which is much more than just a
May 4, 2022

How to Solve MLR Hurdles with a Modular Approach

Find out about the main pain points of MLR approval process and how you can fix and make these actions predictable and faster